Sihong Wang

Sihong Wang HS

Vivoz Biolabs

2021

Technologies

Diagnostic

Indication

Clinical Research

Drug Discovery

Oncology

Personalized Medicine

Executive Summary

View/Download

Additional Information

Minority-Led

Woman-Led

Vivoz Biolabs will develop and commercialize an innovative microfluidic platform first for applications in drug screening/discovery, with the ultimate goal of complimentary diagnosis device for personalized medicine.

2021 PITCH DAY VIDEO

Newsletter Signup

Corporate Supporters

ABCT is a Program of

An initiative of